GLP-1 S (3mg) x 30 Tablets
GLP-1 S (3mg) × 30 Tablets
This single-compound research tablet features GLP-1 S, a synthetic peptide analogue studied for its effects on appetite regulation, glucose modulation, and metabolic signaling. Designed for researchers investigating GLP-1 receptor pathways and energy expenditure, this formulation provides a consistent oral platform for controlled studies in metabolic and endocrine research domains.
Composition (Per Tablet):
GLP-1 S – 3mg
30 tablets per bottle
Key Characteristics:
-
GLP-1 S: Synthetic peptide analogue studied for its influence on GLP-1 receptor activation, glucose balance, and appetite control
-
Supports preclinical research exploring metabolic and endocrine signaling pathways
-
Oral delivery system formulated for compound stability and reproducible dosing
-
Consistent concentration suitable for structured experimental research
Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.